Tuesday, 15 May 2012

New guidelines for the examination of pharmaceutical patents in Argentina

Rodrigo Ramirez Herrera @ramahr May 15, 2012 No comments:

The non-governmental organization Cediquifa (Studies Centre for development chemical - pharmaceutical industry of Argentina) sent for us the following information:

The Argentine Institute of Industrial Property (INPI) in a joint Resolution with the Ministries of Industry and Public Health (Res. Nºs 118/12, 546/12 and 107/12, Official Bulletin 8 May, 2012) issued new guidelines to restrict severely pharmaceutical patents by establishing that many pharmaceutical compounds (salts, polimphors, enantiomers and others) will not be patentable.

According Cedifiquifa, new restrictions are discriminatory and inconsistent with TRIPs.

Source: Félix Rozanski (Cediquifa)

Rodrigo Ramirez Herrera @ramahr

Rodrigo Ramirez Herrera @ramahr

Some IPTango moves

* Listed as one of the "Best blogs on Intellectual and Industrial Property Law". The University of Alicante Intellectual Property & Information Technology Project (UAIPIT).

* One of the only two Latin American blog listed in the "Top 100 Intellectual Property Blogs". Feedspot, as of May 2021.

* Listed as one of the "Top 15 Blogs For An Intellectual Property (IP) Enthusiasts". Buzzfeed.com, January 2017.

* Listed as one of the "World's Best IP Blogs". BananaIP.com, December 2015.

* IPTango founder Professor Jeremy Phillips was listed as one of the Managing Intellectual Property magazine's "Fifty Most Influential People" of 2005, 2011, 2013, and 2014.

* Listed as one of the "Influential intellectual property blawgs". A Dictionary of Intellectual Property Law, Peter Groves, 2011.

* Listed as one of the "Communities of Blawgers". Los blogs jurídicos y la web 2.0. para la difusión y la enseñanza del derecho, Gonzalo Ramírez Cleves, 2010.